Video visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Department
LocationCancer and Hematology Center
Solid Tumor Programs
Bone Tumor Program
Ewing Sarcoma Center
Neuroblastoma Program
Soft Tissue Sarcoma Program
Texas Medical Center
Specialty
Cancer, Blood Disorders
Phone: 832-822-4242
Office Phone
832-824-1471
Email
sbwhittl@texaschildrens.org
Address
6701 Fannin St., Ste. 1510
Houston, TX 77030
Sarah B. Whittle, MD
Director, Soft Tissue Sarcoma Program
Clinical Research Team Lead, Solid Tumor Programs
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Masters | Master of Science, Clinical Investigation | 2016 |
| Baylor College of Medicine | Fellowship | Solid Tumors | 2016 |
| Baylor College of Medicine | Fellowship | Pediatric Hematology-Oncology | 2015 |
| Hasbro Children's Hospital, Brown University | Residency | Pediatrics | 2012 |
| Warren Alpert Medical School at Brown University | Medical School | Doctor of Medicine | 2009 |
| Tufts University | Bachelors | Bachelor of Arts, Biology | 2005 |
About
Dr. Sarah Whittle is the Director of the Soft Tissue Sarcoma Program at Texas Children's Hospital and the leader of the solid tumor clinical research team. She has served as the principal investigator for several clinical trials related to pediatric solid tumors, and is nationally recognized for her expertise in the care of children with these diseases.
Dr. Whittle attended the Warren Alpert School of Medicine at Brown University for medical school, and remained at Brown for her pediatric residency training. She then completed her pediatric hematology-oncology fellowship at Baylor College of Medicine/Texas Children's Hospital, and completed an additional year of training to further specialize in the treatment of pediatric solid tumors. She holds a masters degree in clinical investigation from Baylor College of Medicine. At the national level, Dr. Whittle is a member of the Children's Oncology Group Bone and Soft Tissue Sarcoma committees, and is involved with planning upcoming clinical trials within these groups.
Dr. Whittle treats patients with all pediatric solid tumors including neuroblastoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, and other rare bone and soft tissue sarcomas including synovial sarcoma, liposarcoma, BCOR and CIC-DUX sarcomas, alveolar soft parts sarcoma, and others.
She is board certified by the American Academy of Pediatrics in Pediatrics and in Pediatric Hematology/Oncology.
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society of Pediatric Hematology and Oncology (ASPHO) | Member |
| Children’s Oncology Group (COG) | Member |
| Connective Tissue Oncology Society (CTOS) | Member |
Research Statement
Dr. Whittle is an expert in the design and conduct of clinical trials for pediatric solid tumors. She has served as principal investigator of several investigator initiated, cooperative group, and industry sponsored clinical trials, and currently leads a Children's Oncology Group national phase I-II clinical trial investigating a new agent for use in pediatric solid tumors and lymphoma. At Texas Children's, she is the team leader for clinical research and oversees the conduct of studies that enroll pediatric and adolescent young adult solid tumor patients.
Selected Publications
Awards
2020 Early Career Faculty Award for Excellence in Clinical Care, Baylor College of Medicine
Language
English
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.